Androgens influence estrogen-induced responses in human breast carcinoma cells through cytochrome P450 aromatase

Breast Cancer Research and Treatment

Volumn 44, Issue 1, 1997, Pages 57-64

  Burak Jr , William E ^a,b   Quinn, Anne L ^b   Farrar, William B ^a   Brueggemeier, Robert W ^b  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Androgens; Aromatase; Biosynthesis; Breast; Estrogen

Indexed keywords

7ALPHA (4' AMINOPHENYLTHIO) 1,4 ANDROSTADIENE 3,17 DIONE; ANDROGEN; ANDROSTANOLONE; ANDROSTENEDIONE; AROMATASE; AROMATASE INHIBITOR; CYTOCHROME P450; ESTROGEN; MESSENGER RNA; TAMOXIFEN; TESTOSTERONE; UNCLASSIFIED DRUG;

ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; EPITHELIUM CELL; ESTROGEN SYNTHESIS; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; MESSENGER RNA SYNTHESIS; NORTHERN BLOTTING; PRIORITY JOURNAL;

EID: 8244259187     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005782311558     Document Type: Article

References (31)

1. Cancer Facts and Figures 1995, American Cancer Society, 1995
2. Henderson IC, Canellos GP: Cancer of the breast: the past decade. New Engl J Med 302: 17-30, 78-90, 1980
3. Lippman ME, Dickson RB: Mitogenic regulation of normal and malignant breast epithelium. Yale J Bio Med 62: 459-480, 1989
4. Grodin JM, Siiteri PK, McDonald PC: Source of estrogen production in postmenopausal women. J Clin Endocr Metab 36: 207-214, 1973
5. Miller WR, Forrest APM: Oestradiol synthesis from C19 steroids by human breast cancer. Br J Cancer 33: 16-18, 1974
6. Reed MJ, Hutton JD, Baxendale PM, James VHT, Jacobs HS, Fisher RP: The conversion of androstenedione to oestrone and production of oestrone in women with endometrial cancer. J Steroid Biochem 11: 905-911, 1979
7. Millington DS: Determination of hormonal steroid concentrations in biological extracts by high resolution mass fragmentography. J Steroid Biochem 6: 239-245, 1975
8. Sadekova SI, Tan L, Chow TYK: Identification of the aromatase in the breast carcinoma cell lines T47D and MCF-7. Anticancer Res 14: 507-512, 1994
9. Dowsett M, Macauley V, Gledhill J et al.: Control of aromatase in breast cancer cells and its importance for tumor growth. J Steroid Biochem Mol Biol 44: 605-609, 1993
10. James VHT, McNeill JM, Lai LC, Newton CJ, Ghilchick MW, Reed MJ: Aromatase activity in normal breast and breast tumor tissues: in vivo and in vitro studies. Steroids 50: 269-279, 1987
11. Brooks SC, Locke ER, Soule HD: Estrogen receptor in a human breast cell line (MCF-7) from breast carcinoma. J Biol Chem 248: 6251-6261, 1973
12. Soule HD, McGrath CM: Estrogen responsive proliferation of clonal human breast carcinoma cells in athymic mice. Cancer Letter 10: 177-189, 1980
13. Lippman ME, Dickson RB, Gelmann EP et al.: Growth regulatory peptide production by human breast carcinoma cells. J Steroid Biochem 30: 53-61, 1988
14. Brown AMV, Jeltsch JM, Roberts M, Chambon P: Activation of pS2 gene transcription is a primary response to estrogen in the human breast cancer cell line MCF-7. Proc Natl Acad Sci USA 81: 6344-6348, 1984
15. Sathymoorthy N, Wang TTY, Phang JM: Stimulation of pS2 expression by diet-derived compounds. Cancer Res 54: 957-961, 1994
16. Snider CE, Brueggemeier RW: Potent enzyme-activated inhibition of aromatase by a 7α-substituted C19 steroid. J Biol Chem 262: 8685-8689, 1987
17. Brueggemeier RW, Katlic NE: Effects of the aromatase inhibitor 7α-(4prime;-amino)phenylthio-4-3,17-dione in MCF-7 human mammary carcinoma cell culture. Cancer Res 47: 4548-4551, 1987
18. Brueggemeier RW, Katlic NE: Aromatase inhibition by an enzyme-activated irreversible inhibitor in human carcinoma cells. Cancer Res 50: 3652-3656, 1990
19. Chomcynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987
20. Lephart ED, Simpson ER: Assay of aromatase activity. Methods Enzymol 206: 477-483, 1991
21. Tan L, Muto N: Purification and reconstitution properties of human placental aromatase: cytochrome P-450-type monooxygenase. Eur J Biochem 156: 243-250, 1986
22. Brodie AMH, Wing LY, Goss P, Dowsett M, Coombes RC: Aromatase inhibitors and their potential clinical significance. J Steroid Biochem 25: 859-865, 1986
23. Varela RM, Dao TL: Estrogen synthesis and estradiol binding by human mammary tumors. Cancer Res 38: 2429-2433, 1978
24. Miller WR, Anderson TJ, Jack WJL: Relationship between tumour aromatase activity, tumour characteristics, and response to therapy. J Steroid Biochem Mol Biol 37: 1055-1059, 1990
25. Bezwoda WR, Mansoor N, Dansey R, Esser JD: Aromatisation of androstenedione by human breast cancer tissue: correlation with hormone receptor activity and possible biologic significance. Oncology 44: 30-33, 1987
26. Lipton A, Santner SJ, Santen RJ et al.: Aromatase activity in primary and metastatic human breast cancer. Cancer 59: 779-782, 1987
27. Silva MC, Rowlands MG, Dowsett M et al.: Intratumoral aromatase as a prognostic factor in human breast cancer. Cancer Res 49: 2588-2591, 1989
28. Simpson ER, Mahandroo MS, Means GD et al.: Aromatase cytochrome P-450, the enzyme responsible for estrogen biosynthesis. Endocrine Rev 15: 342-355, 1994
29. Macauley VM, Nicholls JE, Gledhill J et al.: Biological effects of stable overexpression of aromatase in human hormone-dependent breast cancer cells. Br J Cancer 69: 77-83, 1994
30. Dumont M, Luu-Thu V, de Launoit Y, Labrie F: Expression of human 17 beta-hydroxysteroid dehydrogenase in mammalian cells. J Steroid Biochem Mol Biol 41: 605-608, 1992
31. Miller WR, Mullen P: Factors influencing aromatase activity in the breast. J Steroid Biochem Molec Biol 44: 597-604, 1993